WLWT: Avondale man encourages community to consider impact of heart health
UC cardiologist sounds warning about heart disease as part of American Heart Month
Heart disease is the No. 1 killer of women and men. The American Heart Association says cardiovascular disease claims the lives of 1 in 3 women about every 80 seconds. Dr. Hina Jamali, assistant professor in the UC College of Medicine and UC Health cardiologist, told a journalist with WLWT-Channel 5 that medical professionals have to be intentional in educating the community about heart health symptoms.
The most common symptom is chest pain or tightness, but for women, it may not be the most severe, said Jamali. Women are more likely to experience other symptoms like indigestion, back or jaw pain, fatigue or shortness of breath.
Jamali offered her insight as part of American Heart Month; February is designated as such to call attention to heart disease in the United States.
"About 650,000 Americans get affected and are killed by heart disease per year," Jamali said. "We see more men in their younger years -- like 35 plus, 40s -- than women in their age group. Women, I would say it hits them five to 10 years later."
Listen to Dr. Jamali's interview with WLWT-Channel 5
Hear Dr. Jamali speak about National Wear Red Day with WLWT-Channel 5
Related Stories
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
University of Cincinnati graduate programs rise in national rankings across high-demand fields
May 13, 2026
University of Cincinnati graduate programs climbed in the latest U.S. News & World Report rankings, led by strong gains in workforce-focused fields including public health, clinical psychology and business.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.